Literature DB >> 30874342

Germinal center B cell initiation, GC maturation, and the coevolution of its stromal cell niches.

Ann M Haberman1,2, David G Gonzalez1,3, Patrick Wong1, Ting-Ting Zhang1, Steven M Kerfoot4.   

Abstract

Throughout the developing GC response, B cell survival and fate choices made at the single cell level are dependent on signals received largely through interactions with other cells, often with cognate T cells. The type of signals that a given B cell can encounter is dictated by its location within tissue microarchitecture. The focus of this review is on the initiation and evolution of the GC response at the earliest time points. Here, we review the key factors influencing the progression of GC B cell differentiation that are both stage and context dependent. Finally, we describe the coevolution of niches within and surrounding the GC that influence the outcome of the GC response.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  B cells; cell differentiation; cytokines; lineage commitment/specification; stromal cells; transcription factors

Year:  2019        PMID: 30874342     DOI: 10.1111/imr.12731

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  10 in total

Review 1.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

2.  Colloidal Manganese Salt Improves the Efficacy of Rabies Vaccines in Mice, Cats, and Dogs.

Authors:  Zongmei Wang; Yueming Yuan; Chen Chen; Chengguang Zhang; Fei Huang; Ming Zhou; Huanchun Chen; Zhen F Fu; Ling Zhao
Journal:  J Virol       Date:  2021-09-08       Impact factor: 5.103

3.  Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation.

Authors:  Lihui Duan; Dan Liu; Hsin Chen; Michelle A Mintz; Marissa Y Chou; Dmitri I Kotov; Ying Xu; Jinping An; Brian J Laidlaw; Jason G Cyster
Journal:  Immunity       Date:  2021-09-22       Impact factor: 43.474

4.  Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines.

Authors:  Chen Chen; Chengguang Zhang; Ruiming Li; Zongmei Wang; Yueming Yuan; Haoqi Li; Zhenfang Fu; Ming Zhou; Ling Zhao
Journal:  Viruses       Date:  2019-12-03       Impact factor: 5.048

5.  Reduction of Cell Surface T-Cell Receptor by Non-Mitogenic CD3 Antibody to Mitigate Murine Lupus.

Authors:  Masashi Morita; Masayuki Mizui; Satoshi Masuyama; George C Tsokos; Yoshitaka Isaka
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

6.  Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.

Authors:  Chengguang Zhang; Yuling Tian; Chen Chen; Zongmei Wang; Jie Pei; Chuhan Lin; Ming Zhou; Zhen F Fu; Ling Zhao
Journal:  J Virol       Date:  2021-08-04       Impact factor: 5.103

7.  Plasma cells, plasmablasts, and AID+/CD30+ B lymphoblasts inside and outside germinal centres: details of the basal light zone and the outer zone in human palatine tonsils.

Authors:  Birte S Steiniger; Linda Raimer; Anja Ecke; Boris A Stuck; Yalcin Cetin
Journal:  Histochem Cell Biol       Date:  2020-03-14       Impact factor: 4.304

8.  A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies replicon.

Authors:  Ya-Nan Zhang; Chen Chen; Cheng-Lin Deng; Cheng-Guang Zhang; Na Li; Zhen Wang; Ling Zhao; Bo Zhang
Journal:  EBioMedicine       Date:  2020-06-05       Impact factor: 8.143

9.  Histone deacetylase 3 controls a transcriptional network required for B cell maturation.

Authors:  Kristy R Stengel; Srividya Bhaskara; Jing Wang; Qi Liu; Jacob D Ellis; Shilpa Sampathi; Scott W Hiebert
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

10.  Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies.

Authors:  Ronit Gurion; Uri Rozovski; Gilad Itchaki; Anat Gafter-Gvili; Chiya Leibovitch; Pia Raanani; Haim Ben-Zvi; Moran Szwarcwort; Mor Taylor-Abigadol; Eldad J Dann; Nurit Horesh; Tsofia Inbar; Inna Tzoran; Noa Lavi; Riva Fineman; Shimrit Ringelstein-Harlev; Netanel A Horowitz
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.